Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.52 USD | +0.04% | -10.42% | -15.77% |
May. 14 | Transcript : Bioceres Crop Solutions Corp., Q3 2024 Earnings Call, May 14, 2024 | |
May. 14 | Bioceres Crop Solutions Fiscal Q3 Earnings, Revenue Fall | MT |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 67% by 2026.
- The company's profit outlook over the next few years is a strong asset.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Analyst opinion has improved significantly over the past four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- The company benefits from high valuations in earnings multiples.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last few months, analysts have been revising downwards their earnings forecast.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Agricultural Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-15.77% | 723M | - | ||
+16.72% | 39.03B | C | ||
-.--% | 11.3B | - | B+ | |
+1.35% | 8.01B | A | ||
+1.83% | 6.55B | B- | ||
-2.15% | 6.21B | B+ | ||
+38.21% | 5.48B | B- | ||
-14.15% | 5.24B | - | C- | |
-12.97% | 4.59B | C+ | ||
+7.48% | 3.93B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- BIOX Stock
- Ratings Bioceres Crop Solutions Corp.